Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 33 entries
Sorted by: Best Match Show Resources per page
Congenital Absence of Ovaries with Rudimentary Uterus.

British medical journal

Ramage J.
PMID: 20756182
Br Med J. 1896 Apr 25;1(1843):1032. doi: 10.1136/bmj.1.1843.1032.

No abstract available.

Cite
Ramage J. Congenital Absence of Ovaries with Rudimentary Uterus. Br Med J. 1896;1(1843):1032doi: 10.1136/bmj.1.1843.1032.
Ramage, J. (1896). Congenital Absence of Ovaries with Rudimentary Uterus. British medical journal, 1(1843), 1032. https://doi.org/10.1136/bmj.1.1843.1032
Ramage, J. "Congenital Absence of Ovaries with Rudimentary Uterus." British medical journal vol. 1,1843 (1896): 1032. doi: https://doi.org/10.1136/bmj.1.1843.1032
Ramage J. Congenital Absence of Ovaries with Rudimentary Uterus. Br Med J. 1896 Apr 25;1(1843):1032. doi: 10.1136/bmj.1.1843.1032. PMID: 20756182; PMCID: PMC2406759.
Copy Download .nbib Format: NLM
Nodal metastases in small rectal neuroendocrine tumours.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

O'Neill S, Haji A, Ryan S, Clement D, Sarras K, Hayee B, Mulholland N, Ramage JK, Srirajaskanthan R.
PMID: 34731512
Colorectal Dis. 2021 Nov 03; doi: 10.1111/codi.15978. Epub 2021 Nov 03.

AIM: Rectal neuroendocrine tumours (NETs) are the most common type of gastrointestinal NET. European Neuroendocrine Tumour Society guidelines suggest that rectal NETs measuring ≤10 mm are indolent with low risk of spread. In practice, many patients with lesions ≤1...

Cite
O'Neill S, Haji A, Ryan S, et al. Nodal metastases in small rectal neuroendocrine tumours. Colorectal Dis. 2021;doi: 10.1111/codi.15978.
O'Neill, S., Haji, A., Ryan, S., Clement, D., Sarras, K., Hayee, B., Mulholland, N., Ramage, J. K., & Srirajaskanthan, R. (2021). Nodal metastases in small rectal neuroendocrine tumours. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, . https://doi.org/10.1111/codi.15978
O'Neill, Sarah, et al. "Nodal metastases in small rectal neuroendocrine tumours." Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland vol. (2021). doi: https://doi.org/10.1111/codi.15978
O'Neill S, Haji A, Ryan S, Clement D, Sarras K, Hayee B, Mulholland N, Ramage JK, Srirajaskanthan R. Nodal metastases in small rectal neuroendocrine tumours. Colorectal Dis. 2021 Nov 03; doi: 10.1111/codi.15978. Epub 2021 Nov 03. PMID: 34731512.
Copy Download .nbib Format: NLM
Comparative efficacy of tulathromycin and tildipirosin for the treatment of experimental .

Veterinary medicine and science

Bartram DJ, Moyaert H, Vanimisetti BH, Ramage CP, Reddick D, Stegemann MR.
PMID: 29067192
Vet Med Sci. 2016 May 14;2(3):170-178. doi: 10.1002/vms3.31. eCollection 2016 Aug.

The objective of this negative controlled, blinded, randomised, parallel group study was to compare the efficacy of two injectable macrolide antimicrobials, tulathromycin and tildipirosin, administered by single subcutaneous injection at dose rates of 2.5 and 4.0 mg kg

Cite
Bartram DJ, Moyaert H, Vanimisetti BH, et al. Comparative efficacy of tulathromycin and tildipirosin for the treatment of experimental . Vet Med Sci. 2016;2(3):170-178doi: 10.1002/vms3.31.
Bartram, D. J., Moyaert, H., Vanimisetti, B. H., Ramage, C. P., Reddick, D., & Stegemann, M. R. (2016). Comparative efficacy of tulathromycin and tildipirosin for the treatment of experimental . Veterinary medicine and science, 2(3), 170-178. https://doi.org/10.1002/vms3.31
Bartram, David J, et al. "Comparative efficacy of tulathromycin and tildipirosin for the treatment of experimental ." Veterinary medicine and science vol. 2,3 (2016): 170-178. doi: https://doi.org/10.1002/vms3.31
Bartram DJ, Moyaert H, Vanimisetti BH, Ramage CP, Reddick D, Stegemann MR. Comparative efficacy of tulathromycin and tildipirosin for the treatment of experimental . Vet Med Sci. 2016 May 14;2(3):170-178. doi: 10.1002/vms3.31. eCollection 2016 Aug. PMID: 29067192; PMCID: PMC5645867.
Copy Download .nbib Format: NLM
A Systematic Review of Symptoms and Quality of Life Issues in Pancreatic Neuroendocrine Tumours.

Neuroendocrinology

Topping M, Gray D, Friend E, Davies A, Ramage J.
PMID: 28423380
Neuroendocrinology. 2017;105(3):320-330. doi: 10.1159/000475793. Epub 2017 Apr 20.

No abstract available.

Cite
Topping M, Gray D, Friend E, et al. A Systematic Review of Symptoms and Quality of Life Issues in Pancreatic Neuroendocrine Tumours. Neuroendocrinology. 2017;105(3):320-330doi: 10.1159/000475793.
Topping, M., Gray, D., Friend, E., Davies, A., & Ramage, J. (2017). A Systematic Review of Symptoms and Quality of Life Issues in Pancreatic Neuroendocrine Tumours. Neuroendocrinology, 105(3), 320-330. https://doi.org/10.1159/000475793
Topping, Megan, et al. "A Systematic Review of Symptoms and Quality of Life Issues in Pancreatic Neuroendocrine Tumours." Neuroendocrinology vol. 105,3 (2017): 320-330. doi: https://doi.org/10.1159/000475793
Topping M, Gray D, Friend E, Davies A, Ramage J. A Systematic Review of Symptoms and Quality of Life Issues in Pancreatic Neuroendocrine Tumours. Neuroendocrinology. 2017;105(3):320-330. doi: 10.1159/000475793. Epub 2017 Apr 20. PMID: 28423380.
Copy Download .nbib Format: NLM
NMR-Based Strategies to Elucidate Bioactive Conformations of Weakly Binding Ligands.

Topics in current chemistry

Blommers MJ, Strauss A, Geiser M, Ramage P, Sparrer H, Jahnke W.
PMID: 23605457
Top Curr Chem. 2008;273:1-14. doi: 10.1007/128_2007_16.

Key processes in molecular biology are regulated by interactions between biomolecules. Protein-proteinand protein-ligand interactions, e.g., in signal transduction pathways, rely on the subtle interactionsbetween atoms at the binding interface of the involved molecules. Because biomolecules often havemany interacting partners,...

Cite
Blommers MJ, Strauss A, Geiser M, et al. NMR-Based Strategies to Elucidate Bioactive Conformations of Weakly Binding Ligands. Top Curr Chem. 2008;273:1-14doi: 10.1007/128_2007_16.
Blommers, M. J., Strauss, A., Geiser, M., Ramage, P., Sparrer, H., & Jahnke, W. (2008). NMR-Based Strategies to Elucidate Bioactive Conformations of Weakly Binding Ligands. Topics in current chemistry, 2731-14. https://doi.org/10.1007/128_2007_16
Blommers, Marcel J J, et al. "NMR-Based Strategies to Elucidate Bioactive Conformations of Weakly Binding Ligands." Topics in current chemistry vol. 273 (2008): 1-14. doi: https://doi.org/10.1007/128_2007_16
Blommers MJ, Strauss A, Geiser M, Ramage P, Sparrer H, Jahnke W. NMR-Based Strategies to Elucidate Bioactive Conformations of Weakly Binding Ligands. Top Curr Chem. 2008;273:1-14. doi: 10.1007/128_2007_16. PMID: 23605457.
Copy Download .nbib Format: NLM
ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours.

ISRN oncology

Srirajaskanthan R, Ahmed A, Prachialias A, Srinivasan P, Heaton N, Jervis N, Quaglia A, Vivian G, Ramage JK.
PMID: 23533809
ISRN Oncol. 2013;2013:420795. doi: 10.1155/2013/420795. Epub 2013 Feb 28.

Introduction. Small bowel neuroendocrine tumours (NETs) are the most common type of gastrointestinal neuroendocrine tumours. The incidence and prevalence of these tumours are on the rise. The aims of this study were to determine prognostic clinicopathological features and whether...

Cite
Srirajaskanthan R, Ahmed A, Prachialias A, et al. ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours. ISRN Oncol. 2013;2013:420795doi: 10.1155/2013/420795.
Srirajaskanthan, R., Ahmed, A., Prachialias, A., Srinivasan, P., Heaton, N., Jervis, N., Quaglia, A., Vivian, G., & Ramage, J. K. (2013). ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours. ISRN oncology, 2013420795. https://doi.org/10.1155/2013/420795
Srirajaskanthan, Rajaventhan, et al. "ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours." ISRN oncology vol. 2013 (2013): 420795. doi: https://doi.org/10.1155/2013/420795
Srirajaskanthan R, Ahmed A, Prachialias A, Srinivasan P, Heaton N, Jervis N, Quaglia A, Vivian G, Ramage JK. ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours. ISRN Oncol. 2013;2013:420795. doi: 10.1155/2013/420795. Epub 2013 Feb 28. PMID: 23533809; PMCID: PMC3603482.
Copy Download .nbib Format: NLM
Litigation and legislation effects on the school psychologists' role.

Journal of learning disabilities

Ramage JC.
PMID: 7276723
J Learn Disabil. 1981 Aug-Sep;14(7):380-2. doi: 10.1177/002221948101400704.

No abstract available.

Cite
Ramage JC. Litigation and legislation effects on the school psychologists' role. J Learn Disabil. 1981;14(7):380-2doi: 10.1177/002221948101400704.
Ramage, J. C. (1981). Litigation and legislation effects on the school psychologists' role. Journal of learning disabilities, 14(7), 380-2. https://doi.org/10.1177/002221948101400704
Ramage, J C. "Litigation and legislation effects on the school psychologists' role." Journal of learning disabilities vol. 14,7 (1981): 380-2. doi: https://doi.org/10.1177/002221948101400704
Ramage JC. Litigation and legislation effects on the school psychologists' role. J Learn Disabil. 1981 Aug-Sep;14(7):380-2. doi: 10.1177/002221948101400704. PMID: 7276723.
Copy Download .nbib Format: NLM
My Loved One Has Dementia; Is In-Home Care An Option?.

Delaware journal of public health

Eidschun A, Ramage J.
PMID: 34604769
Dela J Public Health. 2021 Sep 27;7(4):86-89. doi: 10.32481/djph.2021.09.010. eCollection 2021 Sep.

No abstract available.

Cite
Eidschun A, Ramage J. My Loved One Has Dementia; Is In-Home Care An Option?. Dela J Public Health. 2021;7(4):86-89doi: 10.32481/djph.2021.09.010.
Eidschun, A., & Ramage, J. (2021). My Loved One Has Dementia; Is In-Home Care An Option?. Delaware journal of public health, 7(4), 86-89. https://doi.org/10.32481/djph.2021.09.010
Eidschun, Anne. "My Loved One Has Dementia; Is In-Home Care An Option?." Delaware journal of public health vol. 7,4 (2021): 86-89. doi: https://doi.org/10.32481/djph.2021.09.010
Eidschun A, Ramage J. My Loved One Has Dementia; Is In-Home Care An Option?. Dela J Public Health. 2021 Sep 27;7(4):86-89. doi: 10.32481/djph.2021.09.010. eCollection 2021 Sep. PMID: 34604769; PMCID: PMC8482990.
Copy Download .nbib Format: NLM
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study.

Frontiers in medicine

Partelli S, Ramage JK, Massironi S, Zerbi A, Kim HB, Niccoli P, Panzuto F, Landoni L, Tomazic A, Ibrahim T, Kaltsas G, Bertani E, Sauvanet A, Segelov E, Caplin M, Coppa J, Armstrong T, Weickert MO, Butturini G, Staettner S, Boesch F, Cives M, Moulton CA, He J, Selberherr A, Twito O, Castaldi A, De Angelis CG, Gaujoux S, Almeamar H, Frilling A, Vigia E, Wilson C, Muffatti F, Srirajaskanthan R, Invernizzi P, Lania A, Kwon W, Ewald J, Rinzivillo M, Nessi C, Smid LM, Gardini A, Tsoli M, Picardi EE, Hentic O, Croagh D, Toumpanakis C, Citterio D, Ramsey E, Mosterman B, Regi P, Gasteiger S, Rossi RE, Smiroldo V, Jang JY, Falconi M.
PMID: 33425946
Front Med (Lausanne). 2020 Dec 23;7:598438. doi: 10.3389/fmed.2020.598438. eCollection 2020.

No abstract available.

Cite
Partelli S, Ramage JK, Massironi S, et al. Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study. Front Med (Lausanne). 2020;7:598438doi: 10.3389/fmed.2020.598438.
Partelli, S., Ramage, J. K., Massironi, S., Zerbi, A., Kim, H. B., Niccoli, P., Panzuto, F., Landoni, L., Tomazic, A., Ibrahim, T., Kaltsas, G., Bertani, E., Sauvanet, A., Segelov, E., Caplin, M., Coppa, J., Armstrong, T., Weickert, M. O., Butturini, G., Staettner, S., Boesch, F., Cives, M., Moulton, C. A., He, J., Selberherr, A., Twito, O., Castaldi, A., De Angelis, C. G., Gaujoux, S., Almeamar, H., Frilling, A., Vigia, E., Wilson, C., Muffatti, F., Srirajaskanthan, R., Invernizzi, P., Lania, A., Kwon, W., Ewald, J., Rinzivillo, M., Nessi, C., Smid, L. M., Gardini, A., Tsoli, M., Picardi, E. E., Hentic, O., Croagh, D., Toumpanakis, C., Citterio, D., Ramsey, E., Mosterman, B., Regi, P., Gasteiger, S., Rossi, R. E., Smiroldo, V., Jang, J. Y., & Falconi, M. (2020). Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study. Frontiers in medicine, 7598438. https://doi.org/10.3389/fmed.2020.598438
Partelli, Stefano, et al. "Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study." Frontiers in medicine vol. 7 (2020): 598438. doi: https://doi.org/10.3389/fmed.2020.598438
Partelli S, Ramage JK, Massironi S, Zerbi A, Kim HB, Niccoli P, Panzuto F, Landoni L, Tomazic A, Ibrahim T, Kaltsas G, Bertani E, Sauvanet A, Segelov E, Caplin M, Coppa J, Armstrong T, Weickert MO, Butturini G, Staettner S, Boesch F, Cives M, Moulton CA, He J, Selberherr A, Twito O, Castaldi A, De Angelis CG, Gaujoux S, Almeamar H, Frilling A, Vigia E, Wilson C, Muffatti F, Srirajaskanthan R, Invernizzi P, Lania A, Kwon W, Ewald J, Rinzivillo M, Nessi C, Smid LM, Gardini A, Tsoli M, Picardi EE, Hentic O, Croagh D, Toumpanakis C, Citterio D, Ramsey E, Mosterman B, Regi P, Gasteiger S, Rossi RE, Smiroldo V, Jang JY, Falconi M. Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study. Front Med (Lausanne). 2020 Dec 23;7:598438. doi: 10.3389/fmed.2020.598438. eCollection 2020. PMID: 33425946; PMCID: PMC7785972.
Copy Download .nbib Format: NLM
Nodal metastases in small rectal neuroendocrine tumours.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

O'Neill S, Haji A, Ryan S, Clement D, Sarras K, Hayee B, Mulholland N, Ramage JK, Srirajaskanthan R.
PMID: 34731512
Colorectal Dis. 2021 Dec;23(12):3173-3179. doi: 10.1111/codi.15978. Epub 2021 Nov 23.

AIM: Rectal neuroendocrine tumours (NETs) are the most common type of gastrointestinal NET. European Neuroendocrine Tumour Society guidelines suggest that rectal NETs measuring ≤10 mm are indolent with low risk of spread. In practice, many patients with lesions ≤1...

Cite
O'Neill S, Haji A, Ryan S, et al. Nodal metastases in small rectal neuroendocrine tumours. Colorectal Dis. 2021;23(12):3173-3179doi: 10.1111/codi.15978.
O'Neill, S., Haji, A., Ryan, S., Clement, D., Sarras, K., Hayee, B., Mulholland, N., Ramage, J. K., & Srirajaskanthan, R. (2021). Nodal metastases in small rectal neuroendocrine tumours. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 23(12), 3173-3179. https://doi.org/10.1111/codi.15978
O'Neill, Sarah, et al. "Nodal metastases in small rectal neuroendocrine tumours." Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland vol. 23,12 (2021): 3173-3179. doi: https://doi.org/10.1111/codi.15978
O'Neill S, Haji A, Ryan S, Clement D, Sarras K, Hayee B, Mulholland N, Ramage JK, Srirajaskanthan R. Nodal metastases in small rectal neuroendocrine tumours. Colorectal Dis. 2021 Dec;23(12):3173-3179. doi: 10.1111/codi.15978. Epub 2021 Nov 23. PMID: 34731512.
Copy Download .nbib Format: NLM
A multimodal approach to the management of neuroendocrine tumour liver metastases.

International journal of hepatology

Basuroy R, Srirajaskanthan R, Ramage JK.
PMID: 22518323
Int J Hepatol. 2012;2012:819193. doi: 10.1155/2012/819193. Epub 2012 Feb 15.

Neuroendocrine tumours (NETs) are often indolent malignancies that commonly present with metastatic disease in the liver. Surgical, locoregional, and systemic treatment modalities are reviewed. A multidisciplinary approach to patient care is suggested to ensure all therapeutic options explored.

Cite
Basuroy R, Srirajaskanthan R, Ramage JK. A multimodal approach to the management of neuroendocrine tumour liver metastases. Int J Hepatol. 2012;2012:819193doi: 10.1155/2012/819193.
Basuroy, R., Srirajaskanthan, R., & Ramage, J. K. (2012). A multimodal approach to the management of neuroendocrine tumour liver metastases. International journal of hepatology, 2012819193. https://doi.org/10.1155/2012/819193
Basuroy, Ron, et al. "A multimodal approach to the management of neuroendocrine tumour liver metastases." International journal of hepatology vol. 2012 (2012): 819193. doi: https://doi.org/10.1155/2012/819193
Basuroy R, Srirajaskanthan R, Ramage JK. A multimodal approach to the management of neuroendocrine tumour liver metastases. Int J Hepatol. 2012;2012:819193. doi: 10.1155/2012/819193. Epub 2012 Feb 15. PMID: 22518323; PMCID: PMC3296190.
Copy Download .nbib Format: NLM
Discovery and structure-based optimization of adenain inhibitors.

ACS medicinal chemistry letters

Mac Sweeney A, Grosche P, Ellis D, Combrink K, Erbel P, Hughes N, Sirockin F, Melkko S, Bernardi A, Ramage P, Jarousse N, Altmann E.
PMID: 25147618
ACS Med Chem Lett. 2014 Jun 20;5(8):937-41. doi: 10.1021/ml500224t. eCollection 2014 Aug 14.

The cysteine protease adenain is the essential protease of adenovirus and, as such, represents a promising target for the treatment of ocular and other adenoviral infections. Through a concise two-pronged hit discovery approach we identified tetrapeptide nitrile 1 and...

Cite
Mac Sweeney A, Grosche P, Ellis D, et al. Discovery and structure-based optimization of adenain inhibitors. ACS Med Chem Lett. 2014;5(8):937-41doi: 10.1021/ml500224t.
Mac Sweeney, A., Grosche, P., Ellis, D., Combrink, K., Erbel, P., Hughes, N., Sirockin, F., Melkko, S., Bernardi, A., Ramage, P., Jarousse, N., & Altmann, E. (2014). Discovery and structure-based optimization of adenain inhibitors. ACS medicinal chemistry letters, 5(8), 937-41. https://doi.org/10.1021/ml500224t
Mac Sweeney, Aengus, et al. "Discovery and structure-based optimization of adenain inhibitors." ACS medicinal chemistry letters vol. 5,8 (2014): 937-41. doi: https://doi.org/10.1021/ml500224t
Mac Sweeney A, Grosche P, Ellis D, Combrink K, Erbel P, Hughes N, Sirockin F, Melkko S, Bernardi A, Ramage P, Jarousse N, Altmann E. Discovery and structure-based optimization of adenain inhibitors. ACS Med Chem Lett. 2014 Jun 20;5(8):937-41. doi: 10.1021/ml500224t. eCollection 2014 Aug 14. PMID: 25147618; PMCID: PMC4137446.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 33 entries